Big Pharma is not shy of admitting the ugly truth about why a decisive cancer cure is not forthcoming soon. That’s the least of their concerns. Continue reading We’re in Business of Shareholder Profit, Not Helping the Sick | Valeant CEO
Big Pharma is not shy of admitting the ugly truth about why a decisive cancer cure is not forthcoming soon. That’s the least of their concerns. Continue reading We’re in Business of Shareholder Profit, Not Helping the Sick | Valeant CEO